Shareholders Sue Cempra Over Pneumonia Drug Safety
The same day that a U.S. Food and Drug Administration advisory panel narrowly voted to approve Cempra Inc's experimental antibiotic drug despite the agency's safety concerns, shareholders hit the company with...To view the full article, register now.
Already a subscriber? Click here to view full article